Nemus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 3.49 Cr
as on 30-07-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.21 Cr
as on 30-07-2024
- Satisfied Charges ₹ 23.06 Cr
as on 30-07-2024
- Revenue 10.23%
(FY 2023)
- Profit 41.21%
(FY 2023)
- Ebitda 20.72%
(FY 2023)
- Net Worth 47.86%
(FY 2023)
- Total Assets 38.35%
(FY 2023)
About Nemus Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.49 Cr.
The company currently has active open charges totaling ₹15.21 Cr. The company has closed loans amounting to ₹23.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravikumar Srinivasa, Sridhar Shetty, Satish Shetty, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2010PTC211145
- Company No.
211145
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Kahalapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nemus Pharmaceuticals Private Limited offer?
Nemus Pharmaceuticals Private Limited offers a wide range of products and services, including Skin Care, Bath Essentials, Hair Care, Hair Oils, Facewash, Sunscreen Products, Ayurveda Products, Natural Hair & Skin Care.
Who are the key members and board of directors at Nemus Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridhar Shetty  | Managing Director | 27-Jul-2011 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravikumar Srinivasa | Director | 12-Jul-2021 | Current |
| Satish Shetty | Director | 31-Aug-2018 | Current |
| Gangadhar Bagodi | Director | 05-Feb-2014 | Current |
| Seenappa Madhukar | Director | 06-Jul-2015 | Current |
| Shashi Shukla | Director | 27-Jul-2021 | Current |
| Venkataraja Chekodu | Director | 27-Jul-2021 | Current |
Financial Performance of Nemus Pharmaceuticals.
Nemus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.23% increase. The company also saw a substantial improvement in profitability, with a 41.21% increase in profit. The company's net worth Soared by an impressive increase of 47.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nemus Pharmaceuticals?
In 2023, Nemus Pharmaceuticals had a promoter holding of 41.75% and a public holding of 58.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pinnacle Data Services Private LimitedActive 18 years 5 monthsRavikumar Srinivasa is a mutual person
Sumukh Wellness Private LimitedActive 12 years 4 daysSridhar Shetty and Satish Shetty are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Sep 2023 | ₹3.68 M | Open |
Hdfc Bank Limited Creation Date: 24 Aug 2023 | ₹14.36 Cr | Open |
Others Creation Date: 10 Jul 2020 | ₹3.00 M | Open |
How Many Employees Work at Nemus Pharmaceuticals?
Nemus Pharmaceuticals has a workforce of 175 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nemus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nemus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
